28.6.2024 14:46:59 CEST | Aqua Bio Technology ASA | Total number of voting rights and capital

Reference is made to the stock exchange announcements made by Aqua Bio Technology ASA ("ABT" or the "Company") on 12 April and 23 April 2024, respectively, regarding the completion of ABT's acquisition of Ovalen AS and the settlement of the earn-out in relation to the Company's acquisition of Cosmed Beauty AS and Ultrabody AB (jointly, "Cosmed").

The Company's board of directors has resolved to issue 1,200,000 consideration shares at a subscription price of NOK 5 per consideration share to the previous owner of Ovalen AS. Moreover, for accounting purposes, the buy-out owed to Varming Holding AS in connection with the Company's acquisition of Cosmed has been rescinded, and the settlement of the buy-out has been agreed to be amended. On this basis, the Company's board of directors has resolved to issue 4,707,935 shares at a subscription price of NOK 4 to Varming Holding AS, with the share deposit being settled by way of set-off.

****

For further information, please contact CEO Håvard Lindstrøm mobile phone +47 941 32 288.

Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skincare products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skincare products developed by partners towards consumers and professional users. ABT's focus on commercialization and development of natural ingredients and natural skincare products has been, and will continue to be, an important part of the Company's strategy going forward. Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange.

This information is considered to be inside information pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. This stock exchange notice was published by CEO Håvard Lindstrøm on the date and time provided.

Disclosure regulation

This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.

Contacts

  • Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

About Aqua Bio Technology ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

Attachments

  • Download announcement as PDF.pdf

© NTB Norway, source NTB English Regulatory Releases